6 Recruiting Lung Non-Small Cell Carcinoma Phase 3 Clinical Trials
Active phase 3 studies for lung non-small cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Lung Non-Small Cell Carcinoma studiesPhase 3 Studies for Lung Non-Small Cell Carcinoma
🔵 Active, Not Recruiting Phase3
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
📍 NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro — Jonesboro, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
📍 Providence Alaska Medical Center — Anchorage, Alaska
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
📍 NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro — Jonesboro, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase3
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
📍 Tower Cancer Research Foundation — Beverly Hills, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔